Boston Children's Hospital picks top pediatric genomic Dx; Bactiguard raises $15M;

@FierceMedDev: Medtronic reports strong leadless pacemaker data as it races St. Jude to FDA approval. More | Follow @FierceMedDev

@VarunSaxena2: IYCMI from FierceDrugDelivery: Physicians call for novel abuse-deterrent opioid agonist/antagonist formulations in survey. Article | Follow @VarunSaxena2

@EmilyWFierce: Theranos and Safeway split after $350M deal, code-named "T-Rex," falls through. More from the WSJ | Follow @EmilyWFierce

> Boston Children's Hospital selected Nationwide Children's Hospital in Columbus, OH as the winner in its pediatric, genomic diagnostics challenge and awarded it a $25,000 prize. Invitae ($NVTA) and Wuxi NextCode were the runners-up. More

> Swedish med tech Bactiguard, which makes antibacterial coated urinary catheters, has raised about $15 million in a credit facility. More

> Startup Kator, which is part of Utah-based incubator Surgical Frontiers, nabbed an FDA clearance for its Suture Anchor System that is designed to be used in arthroscopic rotator cuff repair surgery. It's said to offer double the suture strength of existing suture anchors. More

Biotech News

@FierceBiotech: KIT team points pancreatic cancer therapy toward clinical trials. FierceBiotechResearch article | Follow @FierceBiotech

@JohnCFierce: Ex-Lumena gang pilots new course at Amplyx with antifungal R&D, $40.5M. Report | Follow @JohnCFierce

@DamianFierce: $HZNP "is threatening $ESRX's profiteering and exposing ... a lack of care for patients and respect for physicians." Release | Follow @DamianFierce

> Wave and Voyager keep the IPO train rolling, raising $172M in Wall Street debuts. More

> Boehringer slashes its R&D budget with a new focus on collaboration. Article

Pharma News

@FiercePharma: GeneOne, Inovio's MERS vaccine enters PhI at Walter Reed. Story | Follow @FiercePharma

@EricPFierce: ICYMI: #Novo makes sure Denmark gets some of the action as it starts massive build up. More | Follow @EricPFierce

@CarlyHFierce: $GSK shoots for diabetes-esque platform approach with new respiratory med in hand. Article | Follow @CarlyHFierce

> Bondholders bail on Valeant amid cash flow concerns. More

> Sources: Novartis faces yet another sanction in Japan. Article

Biotech Research News

> MD Anderson group tracks 'modest' impact of lymphoma drug. Item

> Warp Drive Bio constructs a new cancer R&D tech platform. Story

> Microbiome study highlights bacterial strategy for treating severe diarrhea. News

> Case Western researchers spotlight role of rapid protein movement in hearing loss. More

> KIT team points pancreatic cancer therapy toward clinical trials. Article

Vaccines News

> GeneOne, Inovio's MERS vaccine enters PhI at Walter Reed. News

> MenAfriVac succeeds in sub-Saharan Africa, but the fight isn't over yet. More

> James Cook University researcher wins $2M Gates grant for malaria vaccine development. Story

> Novavax kicks off PhIII trial for its RSV vaccine. Article

> EMA safety review raises no issues with HPV vaccines from Merck, GSK. Report

Pharma Marketing News

> $1-per-pill alternative to Turing drug gets 'overwhelming' response: Imprimis CEO. Article

> Medivation's Xtandi sales force due for hiring, revamp as urology push falls flat. Report

> GSK shoots for diabetes-esque platform approach with new respiratory med in hand. More

> Allergan counting on January formulary boost to jump-start Namzaric launch. Story

> AstraZeneca holds on to purple Nexium trademark with early court win. Article

Suggested Articles

Grail published new data showing that its cancer-screening blood test is now able to spot more than 50 types of the disease and across all stages.

Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for N95 respirator masks.

The limited supply of ventilators is one of the chief concerns facing hospitals as they prepare for more COVID-19 cases.